Izraēla - angļu - Ministry of Health

dexcel ltd, israel - chlorpheniramine maleate; dextromethorphan hydrobromide; paracetamol; pseudoephedrine hydrochloride - caplets - paracetamol 500 mg; chlorpheniramine maleate 2 mg; dextromethorphan hydrobromide 10 mg; pseudoephedrine hydrochloride 25 mg - pseudoephedrine, combinations - pseudoephedrine, combinations - for the symptomatic relief of cold, cough and nasal congestion accompanied by fever and pain, for treatment at night.

Izraēla - angļu - Ministry of Health

dexcel ltd, israel - chlorpheniramine maleate; dextromethorphan hydrobromide; paracetamol; pseudoephedrine hydrochloride - caplets - paracetamol 500 mg; chlorpheniramine maleate 2 mg; dextromethorphan hydrobromide 10 mg; pseudoephedrine hydrochloride 25 mg - pseudoephedrine, combinations - pseudoephedrine, combinations - for the symptomatic relief of cold, cough and nasal congestion accompanied by fever and pain, for treatment at night.

Izraēla - angļu - Ministry of Health

dexcel ltd, israel - dextromethorphan hydrobromide; guaifenesin; paracetamol; pseudoephedrine hydrochloride - caplets - paracetamol 325 mg; guaifenesin 200 mg; dextromethorphan hydrobromide 10 mg; pseudoephedrine hydrochloride 25 mg - dextromethorphan - dextromethorphan - for the symptomatic relief of cold, cough and nasal congestion accompanied by fever and pain, for day care.

Izraēla - angļu - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 10 mg - methylphenidate - methylphenidate - attention deficit hyperactivity disorder (adhd). narcolepsy.

Izraēla - angļu - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorders . narcolepsy.

Izraēla - angļu - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd) .

Izraēla - angļu - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).

Izraēla - angļu - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 30 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).

Izraēla - angļu - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 40 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 10 mg; naloxone hydrochloride (as dihydrate) 5 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.